Abstract
Off-label use: Patient, surgeon & industry
Highlights
What does this have to do with Foot & Ankle Surgery: Techniques, Reports & Cases (FASTRAC)? Well, I have witnessed an influx of submissions that involve patients receiving care with “off-label use.” As defined by the United States Food & Drug Administration (US FDA), off-label use is, “. . .prescribing medications for indications, or using a dosage or dosage form, that have not been approved by the US FDA”.1 Interestingly, much of what we do as foot & ankle surgeons involves off-label drug or product use.[2]
One benefit for our industry partners is that they can better understand how their products are being employed by foot & ankle surgeons
The foot & ankle surgeons reading FASTRAC will be able to determine if the approach taken by the authors warrants the potential medical-legal risks associated with offlabel drug or product use in their own practices
Summary
What does this have to do with Foot & Ankle Surgery: Techniques, Reports & Cases (FASTRAC)? Well, I have witnessed an influx of submissions that involve patients receiving care with “off-label use.” As defined by the United States Food & Drug Administration (US FDA), off-label use is, “. . .prescribing medications for indications, or using a dosage or dosage form, that have not been approved by the US FDA”.1 Interestingly, much of what we do as foot & ankle surgeons involves off-label drug or product use.[2].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.